{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:19Z","timestamp":1761824659476,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["98-02-27-42488"],"award-info":[{"award-number":["98-02-27-42488"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["982730"],"award-info":[{"award-number":["982730"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.advms.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T03:08:00Z","timestamp":1662433680000},"page":"338-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma"],"prefix":"10.1016","volume":"67","author":[{"given":"Shaghayegh","family":"Rahdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Alireza","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorour","family":"Shojaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazel","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-341X","authenticated-orcid":false,"given":"Mohammad Mehdi","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4503-299X","authenticated-orcid":false,"given":"Amir-Hassan","family":"Zarnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.critrevonc.2017.05.001","article-title":"Melanoma antigens and related immunological markers","volume":"115","author":"Pitcovski","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib2","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-017-0458-3","article-title":"The use of immunotherapy in the treatment of melanoma","volume":"10","author":"Achkar","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"issue":"5 Suppl 1","key":"10.1016\/j.advms.2022.08.002_bib4","first-page":"S78","article-title":"Melanoma survival in the United States, 1992 to 2005","volume":"65","author":"Pollack","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.advms.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00262-019-02350-8","article-title":"PLAC1: biology and potential application in cancer immunotherapy","volume":"68","author":"Mahmoudian","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.advms.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2021.06.001","article-title":"PLAC1 affects cell to cell communication by interacting with the desmosome complex","volume":"110","author":"Chen","year":"2021","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.advms.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/pd.2506","article-title":"PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology","volume":"30","author":"Fant","year":"2010","journal-title":"Prenat Diagn"},{"issue":"19","key":"10.1016\/j.advms.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1158\/0008-5472.CAN-07-1350","article-title":"placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes","volume":"67","author":"Koslowski","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib9","first-page":"10","article-title":"Isolation and partial characterization of human amniotic epithelial cells: the effect of trypsin","volume":"6","author":"Tabatabaei","year":"2014","journal-title":"Avicenna J Med Biotechnol (AJMB)"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13682-9","article-title":"Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy","volume":"7","author":"Nejadmoghaddam","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.advms.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/08923973.2020.1837865","article-title":"Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target","volume":"42","author":"Mahmoudi","year":"2020","journal-title":"Immunopharmacol Immunotoxicol"},{"year":"2021","series-title":"Optimization of expression and purification of recombinant mouse plac1","author":"Rahdan","key":"10.1016\/j.advms.2022.08.002_bib12"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-1.12743","article-title":"Expression profiling of plac1 in murine cancer cell lines","volume":"41","author":"Mahmoudian","year":"2019","journal-title":"Exp Oncol"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib14","first-page":"20","article-title":"Expression, purification and characterization of three overlapping immunodominant recombinant fragments from bordetella pertussis filamentous hemagglutinin","volume":"5","author":"Asgarian-Omran","year":"2013","journal-title":"Avicenna J Med Biotechnol (AJMB)"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46316-3","article-title":"Human menstrual blood-derived stromal\/stem cells modulate functional features of natural killer cells","volume":"9","author":"Shokri","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.advms.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/bab.1177","article-title":"Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta-specific 1","volume":"61","author":"Ghods","year":"2014","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10555-014-9542-0","article-title":"Immunotherapy of melanoma: present options and future promises","volume":"34","author":"Rotte","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.advms.2022.08.002_bib18","series-title":"Janeway's immunobiology","first-page":"904","author":"Murphy","year":"2016"},{"issue":"2","key":"10.1016\/j.advms.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc2326","article-title":"DNA vaccines: precision tools for activating effective immunity against cancer","volume":"8","author":"Rice","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biologicals.2014.11.001","article-title":"Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice","volume":"43","author":"Nezafat","year":"2015","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.advms.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1053\/j.gastro.2008.01.029","article-title":"The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients","volume":"134","author":"Liu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2022.08.002_bib22","first-page":"18","article-title":"PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses","volume":"7","author":"Silva","year":"2007","journal-title":"Cancer Immun"},{"issue":"6925","key":"10.1016\/j.advms.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.advms.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/hum.2009.067","article-title":"DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer","volume":"20","author":"Low","year":"2009","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.advms.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/cgt.2013.60","article-title":"Potent CD4+ T-cell epitope P30 enhances HER2\/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses","volume":"20","author":"Xie","year":"2013","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"10.1016\/j.advms.2022.08.002_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1089\/hgtb.2016.114","article-title":"Preclinical evaluation of a replication-deficient recombinant adenovirus serotype 5 vaccine expressing guanylate cyclase C and the PADRE T-helper epitope","volume":"27","author":"Snook","year":"2016","journal-title":"Hum Gene Ther Methods"},{"issue":"1","key":"10.1016\/j.advms.2022.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1856545","article-title":"Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma","volume":"10","author":"Hayashi","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.advms.2022.08.002_bib28","series-title":"Cancer immunology","first-page":"293","article-title":"Monoclonal antibodies for cancer immunotherapy","author":"Zarnani","year":"2015"},{"issue":"6","key":"10.1016\/j.advms.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2012.02.034","article-title":"Antibody-based immunotherapy of cancer","volume":"148","author":"Weiner","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.advms.2022.08.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111938","article-title":"Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones","volume":"391","author":"Dias Camara","year":"2020","journal-title":"Exp Cell Res"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:57Z","timestamp":1761824457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112622000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1896112622000311"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2022.08.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}